Brain metabolic differences between sporadic and familial Alzheimer's disease.

scientific article published in October 2003

Brain metabolic differences between sporadic and familial Alzheimer's disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/01.WNL.0000086816.30011.75
P698PubMed publication ID14581683

P50authorBenedetta NacmiasQ30434373
Alberto PupiQ43212796
Elena CelliniQ53995268
Maria Teresa De CristofaroQ59680222
Karl HerholzQ67216139
P2093author name stringL Bracco
L Mosconi
S Bagnoli
S Sorbi
M Fayyaz
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
P304page(s)1138-1140
P577publication date2003-10-01
P1433published inNeurologyQ1161692
P1476titleBrain metabolic differences between sporadic and familial Alzheimer's disease
P478volume61

Reverse relations

cites work (P2860)
Q24625859Brain fuel metabolism, aging, and Alzheimer's disease
Q30984127Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
Q35120662Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment
Q57178032Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease
Q42431887Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease
Q44680131Dual task abilities as a possible preclinical marker of Alzheimer's disease in carriers of the E280A presenilin-1 mutation.
Q35483725Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve
Q33581218Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease
Q57800439Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease
Q36136747Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development

Search more.